Suguru Yamamoto Selected Research

Inflammation (Inflammations)

2/2019	Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β2-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis-Oshima Award Address 2016.
1/2018	Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.
12/2012	Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.
8/2011	Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.
5/2009	Mechanisms for increased cardiovascular disease in chronic kidney dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suguru Yamamoto Research Topics

Disease

20	Chronic Renal Insufficiency 04/2024 - 05/2007
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2018 - 07/2012
10	Neoplasms (Cancer) 02/2018 - 05/2009
9	Secondary Hyperparathyroidism 04/2024 - 03/2005
9	Amyloidosis 02/2024 - 09/2003
8	Atherosclerosis 04/2021 - 05/2009
5	Inflammation (Inflammations) 02/2019 - 05/2009
4	Chronic Kidney Failure (Chronic Renal Failure) 02/2024 - 12/2012
4	Adenocarcinoma 02/2018 - 07/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 12/2012
3	Diabetes Mellitus 04/2024 - 12/2013
3	Hyperphosphatemia 01/2022 - 01/2015
3	Idiopathic Interstitial Pneumonias 01/2021 - 01/2019
3	Pain (Aches) 07/2018 - 01/2006
3	Rheumatoid Arthritis 03/2018 - 01/2012
3	Disease Progression 01/2018 - 11/2013
3	Kidney Diseases (Kidney Disease) 10/2017 - 08/2011
3	Lung Neoplasms (Lung Cancer) 08/2015 - 10/2004
2	Frailty 04/2024 - 02/2024
2	Hypophosphatemia 04/2024 - 10/2019
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2021 - 04/2017
2	Uremia 01/2021 - 01/2018
2	Idiopathic Pulmonary Fibrosis 01/2020 - 01/2019
2	Polyps 01/2020 - 01/2019
2	Iron Deficiencies 08/2018 - 01/2015
2	Hyponatremia 05/2018 - 01/2017
2	Infections 03/2018 - 01/2012
2	Osteoporosis 01/2018 - 09/2016
2	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 10/2017 - 07/2009
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 01/2016
2	Fever (Fevers) 01/2017 - 01/2006
2	Dyspnea (Shortness of Breath) 01/2017 - 01/2015
2	Anemia 01/2017 - 01/2016
2	Insulin Resistance 12/2016 - 12/2013
2	Bone Diseases (Bone Disease) 09/2016 - 06/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2015 - 01/2014
2	Arthralgia (Joint Pain) 01/2012 - 11/2005
2	Necrosis 12/2011 - 08/2011
2	Carpal Tunnel Syndrome 05/2007 - 11/2005
2	Bone Cysts (Bone Cyst) 05/2007 - 11/2005
2	Spondylarthropathies 05/2007 - 11/2005
1	Hypocalcemia 04/2024
1	Pruritus (Itching) 01/2024
1	Hemolysis 12/2023
1	Urinary Tract Infections (Urinary Tract Infection) 07/2023
1	Xanthogranulomatous Pyelonephritis 07/2023
1	Atrial Fibrillation 06/2023
1	Heart Failure 06/2023
1	COVID-19 12/2022
1	Pneumothorax 12/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2006
10	Amyloid (Amyloid Fibrils)IBA 02/2024 - 01/2004
10	Uremic ToxinsIBA 01/2024 - 08/2011
8	Parathyroid Hormone (Parathormone)IBA 11/2023 - 06/2005
7	Phosphates (Orthophosphate)IBA 01/2022 - 06/2005
5	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2017
5	CholesterolIBA 02/2019 - 05/2009
5	ErbB Receptors (EGF Receptor)IBA 02/2018 - 07/2012
4	IndicanIBA 04/2021 - 08/2015
4	MineralsIBA 01/2018 - 05/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 01/2013
4	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 01/2013
3	C-Reactive ProteinIBA 04/2024 - 01/2006
3	CytokinesIBA 01/2021 - 12/2012
3	ThrombomodulinIBA 01/2021 - 01/2019
3	HDL LipoproteinsIBA 02/2019 - 12/2012
3	Pemetrexed (MTA)FDA Link 01/2018 - 07/2012
3	Apolipoproteins E (ApoE)IBA 12/2011 - 03/2005
3	ApolipoproteinsIBA 08/2011 - 03/2005
3	Proteoglycans (Proteoglycan)IBA 11/2005 - 09/2003
3	GlycosaminoglycansIBA 11/2005 - 09/2003
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 12/2012
2	PolyphosphatesIBA 01/2020 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 12/2012
2	CalciumIBA 10/2019 - 06/2005
2	ferric citrateIBA 08/2018 - 01/2015
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2017 - 01/2016
2	Angiotensin Receptor AntagonistsIBA 09/2015 - 01/2015
2	Opioid Analgesics (Opioids)IBA 08/2015 - 01/2014
2	Gemcitabine FDA Link 01/2015 - 01/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2013 - 07/2012
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2008 - 03/2005
1	Cinacalcet (Sensipar)FDA Link 04/2024
1	CelluloseIBA 02/2024
1	Vitamin D FDA LinkGeneric 11/2023
1	AA amyloidosisIBA 07/2023
1	Atrial Natriuretic Factor (ANF)IBA 06/2023
1	MagnesiumIBA 08/2022

Therapy/Procedure

17	Renal Dialysis (Hemodialysis) 04/2024 - 01/2009
17	Therapeutics 01/2021 - 03/2005
8	Drug Therapy (Chemotherapy) 02/2018 - 12/2012
2	Hemodiafiltration 11/2023 - 11/2016
2	Tonsillectomy 01/2021 - 04/2017
2	Kidney Transplantation 10/2019 - 11/2005
2	Activities of Daily Living (ADL) 07/2018 - 01/2014
2	Combination Drug Therapy (Combination Chemotherapy) 01/2015 - 07/2012
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2023
1	Pleurodesis 12/2022